Acumen Pharmaceuticals Inc (ABOS) showcases promising developments in Alzheimer's treatment and cost management, despite reporting a net loss for the quarter.

Non-hardware investments in artificial intelligence could surpass $1 trillion globally in the coming years, Goldman Sachs said, as companies pour money into data infrastructure, software and ...

Ironically, a policy designed to reduce investor influence in the housing market could have the opposite effect on liquidity.

Dalaroo Metals Ltd (ASX:DAL) has completed a large-scale systematic soil geochemistry program across the Gold Ridge Prospect ...

Auravelle Metals Ltd (ASX:AUV) is preparing to start its next round of reverse circulation (RC) drilling at the Nuckulla Hill ...

Clicking on the wrong ad has seen some Aussies lose an immense amount of their retirement savings. The industry wants them ...

Bank of America just got even more bullish on CoreWeave (CRWV), spearheaded by the market’s insatiable demand for AI ...

Koonenberry Gold Ltd (ASX:KNB) has extended gold mineralisation at the Sunnyside Prospect within its Enmore Project in ...

Industrial services gained the most among New Zealand sectors on Tuesday, advancing nearly 1%. Ventia Services Group's ...

Wall Street’s AI trade is starting to look increasingly split between believers and sceptics. In the space of just a few days ...

Australian shares are poised to open higher on Tuesday, tracking another record-setting session on Wall Street as investors ...

Materials stocks advanced over 2% to lead gainers in midday trading on Tuesday amid a broadly lower market ahead of the ...